These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33334614)

  • 1. Identification of patients at risk of Clostridioides difficile infection for enrollment in vaccine clinical trials.
    Stevens VW; Russo EM; Young-Xu Y; Leecaster M; Zhang Y; Zhang C; Yu H; Cai B; Gonzalez EN; Gerding DN; Lawrence J; Samore MH
    Vaccine; 2021 Jan; 39(3):536-544. PubMed ID: 33334614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials.
    Baggs J; Yousey-Hindes K; Ashley ED; Meek J; Dumyati G; Cohen J; Wise ME; McDonald LC; Lessa FC
    Vaccine; 2015 Nov; 33(46):6241-9. PubMed ID: 26450660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci.
    Stevens VW; Khader K; Echevarria K; Nelson RE; Zhang Y; Jones M; Timbrook TT; Samore MH; Rubin MA
    Clin Infect Dis; 2020 Jul; 71(3):645-651. PubMed ID: 31504328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a risk assessment model to predict infection with healthcare facility-onset Clostridioides difficile.
    Tilton CS; Sexton ME; Johnson SW; Gu C; Chen Z; Robichaux C; Metzger NL
    Am J Health Syst Pharm; 2021 Sep; 78(18):1681-1690. PubMed ID: 33954428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suggestions for the prevention of Clostridioides difficile spread within outpatient hemodialysis facilities.
    D'Agata EMC; Apata IW; Booth S; Boyce JM; Deaver K; Gualandi N; Neu A; Nguyen D; Novosad S; Palevsky PM; Rodgers D;
    Kidney Int; 2021 May; 99(5):1045-1053. PubMed ID: 33667504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales.
    Tydeman F; Craine N; Kavanagh K; Adams H; Reynolds R; McClure V; Hughes H; Hickman M; Robertson C
    J Antimicrob Chemother; 2021 Aug; 76(9):2437-2445. PubMed ID: 34151964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Clostridioides difficile Infection Among Asymptomatic, Colonized Patients: A Retrospective Cohort Study.
    Poirier D; Gervais P; Fuchs M; Roussy JF; Paquet-Bolduc B; Trottier S; Longtin J; Loo VG; Longtin Y
    Clin Infect Dis; 2020 May; 70(10):2103-2210. PubMed ID: 31290544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SEASON GAP score: A predictor of Clostridioides difficile infection among patients with tube feeding.
    Masaki M; Matsuo T; Kobayashi D; Mori N
    J Infect Chemother; 2022 Aug; 28(8):1131-1137. PubMed ID: 35440369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
    Wang Y; Schluger A; Li J; Gomez-Simmonds A; Salmasian H; Freedberg DE
    Clin Infect Dis; 2020 Dec; 71(9):2414-2420. PubMed ID: 31714955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the potential impact of administering vaccines against Clostridioides difficile infection to individuals in healthcare facilities.
    Toth DJA; Keegan LT; Samore MH; Khader K; O'Hagan JJ; Yu H; Quintana A; Swerdlow DL
    Vaccine; 2020 Aug; 38(37):5927-5932. PubMed ID: 32703744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Clostridioides difficile recurrence across a national cohort of veterans in outpatient, acute, and long-term care settings.
    Appaneal HJ; Caffrey AR; Beganovic M; Avramovic S; LaPlante KL
    Am J Health Syst Pharm; 2019 Apr; 76(9):581-590. PubMed ID: 31361830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [i]Clostridioides difficile[/i] infection in patients with end stage renal disease. Is it preventable?
    Lis Ł; Konieczny A; Żłobicka K; Witkiewicz W; Hruby Z
    Przegl Epidemiol; 2020; 74(1):11-21. PubMed ID: 32500979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigating the association of room features with healthcare-facility-onset
    Root ED; Lindstrom M; Xie A; Mangino JE; Moffatt-Bruce S; Hebert C
    Infect Control Hosp Epidemiol; 2021 Jul; 42(7):847-852. PubMed ID: 33261688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridioides difficile infection in a long-term convalescence hospital: A real tale of pitfalls and outdated therapy.
    Esteban-Rihuete M; Moreno-Borraz L; Rodríguez-Gascón D; García-Herrero JC; García-Lechuz JM; García-Forcada A
    Rev Esp Quimioter; 2021 Feb; 34(1):51-55. PubMed ID: 33258362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridioides difficile infections in Alberta: The validity of administrative data using ICD-10 diagnostic codes for CDI surveillance versus clinical infection surveillance.
    Pfister T; Rennert-May E; Ellison J; Bush K; Leal J
    Am J Infect Control; 2020 Dec; 48(12):1431-1436. PubMed ID: 32810568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridioides difficile infection in US hospitals: a national inpatient sample study.
    Ramai D; Dang-Ho KP; Lewis C; Fields PJ; Ofosu A; Barakat M; Aamar A; Ofori E; Lai J; Lanke G; Dhaliwal A; Reddy M; Gasperino J
    Int J Colorectal Dis; 2020 Oct; 35(10):1929-1935. PubMed ID: 32556651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interpretation of group standard for
    Wu Y; Lu JX; Yan ZZ; Liu YX; Gu WP; Fu XQ; Xu YC; Wu AH; Huang HH; Zong ZY; Jin DZ; Zhao JH; Chen Y; Liu WP; Li WG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):64-67. PubMed ID: 33503698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modest Clostridiodes difficile infection prediction using machine learning models in a tertiary care hospital.
    Marra AR; Alzunitan M; Abosi O; Edmond MB; Street WN; Cromwell JW; Salinas JL
    Diagn Microbiol Infect Dis; 2020 Oct; 98(2):115104. PubMed ID: 32650284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.